$UHG
United Homes Group, Inc.

2023 Q1 Form 10-Q Financial Statement

#000110465923060949 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $94.83M $115.1M $0.00
YoY Change
Cost Of Revenue $78.05M $93.50M $81.16M
YoY Change -3.84% -28.08%
Gross Profit $16.78M $21.60M $27.27M
YoY Change -38.48% -39.5%
Gross Profit Margin 17.69% 18.77%
Selling, General & Admin $16.69M $10.70M $185.3K
YoY Change 8907.07% 4864.51% -73.17%
% of Gross Profit 99.46% 49.54% 0.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $93.94K $100.0K $86.83K
YoY Change 8.19% 11.11%
% of Gross Profit 0.56% 0.46% 0.32%
Operating Expenses $16.69M $10.80M $185.3K
YoY Change 8907.07% 4910.9% -73.17%
Operating Profit $90.37K $10.80M -$185.3K
YoY Change -148.78% -69.56% -73.17%
Interest Expense -$206.7M $300.0K $28.16K
YoY Change -734119.89% 4487.16% -106.32%
% of Operating Profit -228721.29% 2.78%
Other Income/Expense, Net $202.7K -$200.0K $3.785M
YoY Change -94.64% -145.79% -10.91%
Pretax Income -$206.5M $10.90M $3.628M
YoY Change -5792.47% 4685.74% 16.55%
Income Tax -$2.021M $0.00
% Of Pretax Income 0.0%
Net Earnings -$204.5M $10.90M $3.628M
YoY Change -5736.76% 4685.74% 16.55%
Net Earnings / Revenue -215.66% 9.47%
Basic Earnings Per Share -$5.44 $0.46
Diluted Earnings Per Share -$5.44 $0.23 $84.13K
COMMON SHARES
Basic Shares Outstanding 37.58M 37.35M
Diluted Shares Outstanding 37.58M 37.35M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.9M $12.20M $108.2K
YoY Change 102376.44% 4729.77% -90.84%
Cash & Equivalents $110.9M $37.00K $108.0K
Short-Term Investments
Other Short-Term Assets $6.400M $3.600M $233.4K
YoY Change 2642.07% 1399.5% -42.91%
Inventory $150.1M $180.2M
Prepaid Expenses $20.02K $233.4K
Receivables $1.700M $2.000M
Other Receivables $800.0K $1.400M
Total Short-Term Assets $269.9M $56.70K $341.6K
YoY Change 78905.22% -88.49% -78.52%
LONG-TERM ASSETS
Property, Plant & Equipment $676.4K $1.386M
YoY Change
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $400.0K $200.0K $345.0M
YoY Change -99.88% -99.94% 0.01%
Other Assets $3.900M
YoY Change
Total Long-Term Assets $13.87M $349.2M $345.0M
YoY Change -95.98% 1.2% 0.01%
TOTAL ASSETS
Total Short-Term Assets $269.9M $56.70K $341.6K
Total Long-Term Assets $13.87M $349.2M $345.0M
Total Assets $283.8M $349.2M $345.4M
YoY Change -17.84% 1.07% -0.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.40M $100.3K $109.8K
YoY Change 12099.34% 84.41% -63.27%
Accrued Expenses $5.900M $3.660M $50.00K
YoY Change 11700.0% 2950.24% -90.83%
Deferred Revenue $305.7K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.00M $4.446M $323.3K
YoY Change 6087.09% 1438.26% -61.81%
LONG-TERM LIABILITIES
Long-Term Debt $175.9M $120.8M $0.00
YoY Change
Other Long-Term Liabilities $451.1M $17.08M
YoY Change 2540.46% -18.6%
Total Long-Term Liabilities $627.0M $120.8M $17.08M
YoY Change 3570.06% 478.84% -18.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.00M $4.446M $323.3K
Total Long-Term Liabilities $627.0M $120.8M $17.08M
Total Liabilities $647.0M $5.977M $17.41M
YoY Change 3616.97% -71.75% -20.28%
SHAREHOLDERS EQUITY
Retained Earnings -$363.3M -$5.355M -$17.02M
YoY Change 2034.62% -74.06% -647.04%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$363.3M -$5.354M -$17.02M
YoY Change
Total Liabilities & Shareholders Equity $283.8M $349.2M $345.4M
YoY Change -17.84% 1.07% -0.35%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$204.5M $10.90M $3.628M
YoY Change -5736.76% 4685.74% 16.55%
Depreciation, Depletion And Amortization $93.94K $100.0K $86.83K
YoY Change 8.19% 11.11%
Cash From Operating Activities $23.05M $14.96M -$74.38K
YoY Change -31091.15% -16742.56% -84.7%
INVESTING ACTIVITIES
Capital Expenditures $59.23K $50.00K $19.30K
YoY Change 206.97% -50.0%
Acquisitions
YoY Change
Other Investing Activities $70.00K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $6.871K -$60.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.700M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 75.61M -22.04M -70.00K
YoY Change -108119.82% -100.02%
NET CHANGE
Cash From Operating Activities 23.05M 14.96M -74.38K
Cash From Investing Activities 6.871K -60.00K 0.000
Cash From Financing Activities 75.61M -22.04M -70.00K
Net Change In Cash 98.67M -7.140M -144.4K
YoY Change -68441.33% 7843.04% -112.39%
FREE CASH FLOW
Cash From Operating Activities $23.05M $14.96M -$74.38K
Capital Expenditures $59.23K $50.00K $19.30K
Free Cash Flow $22.99M $14.91M -$93.68K
YoY Change -24644.56% -7951.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001830188
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
785012
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39936
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
United Homes Group, Inc.
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3460766
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
90 N Royal Tower Drive,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irmo
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
SC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
29063
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
572-6260
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110911416
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1976334
CY2023Q1 uhg Inventoryhomesunderconstructionandfinishedhomes
Inventoryhomesunderconstructionandfinishedhomes
128950892
CY2022Q4 uhg Inventoryhomesunderconstructionandfinishedhomes
Inventoryhomesunderconstructionandfinishedhomes
163997487
CY2023Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
21189983
CY2022Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
16205448
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12238835
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1693064
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
125987
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
1437235
CY2023Q1 uhg Related Party Note Receivable
RelatedPartyNoteReceivable
665020
CY2023Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
8113303
CY2022Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
3804436
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
431894
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
186086
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
676408
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1385698
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
768282
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1001277
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3891575
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6350037
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6112044
CY2023Q1 us-gaap Assets
Assets
283767861
CY2022Q4 us-gaap Assets
Assets
208344880
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
13414465
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
22077240
CY2023Q1 uhg Debt And Other Affiliate Debt Current And Noncurrent
DebtAndOtherAffiliateDebtCurrentAndNoncurrent
109172986
CY2022Q4 uhg Debt And Other Affiliate Debt Current And Noncurrent
DebtAndOtherAffiliateDebtCurrentAndNoncurrent
120797006
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
768282
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1001277
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
5150413
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
5465321
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
701871
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
451106576
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
66714276
CY2023Q1 us-gaap Liabilities
Liabilities
647028869
CY2022Q4 us-gaap Liabilities
Liabilities
149340844
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1422630
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363265766
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57577672
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-363261008
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
59004036
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
283767861
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
208344880
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94826702
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108436860
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
78048929
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
81164960
CY2023Q1 us-gaap Gross Profit
GrossProfit
16777773
CY2022Q1 us-gaap Gross Profit
GrossProfit
27271900
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16687401
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10425050
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
90372
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
16846850
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
202715
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
171078
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
245808
CY2023Q1 uhg Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
207064488
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-206525593
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17017928
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2021265
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-204504328
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17017928
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.44
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.44
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37575074
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37347350
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37575074
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37347350
CY2021Q4 uhg Stockholders Equity Attributable To Parent As Originally Reported
StockholdersEquityAttributableToParentAsOriginallyReported
66558412
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
66558412
CY2022Q1 uhg Stockholders Equity Period Decrease Increase From Distributions And Net Transfer To Shareholders And Other Affiliates
StockholdersEquityPeriodDecreaseIncreaseFromDistributionsAndNetTransferToShareholdersAndOtherAffiliates
20766162
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1268222
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17017928
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64078400
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59004036
CY2023Q1 uhg Stockholders Equity Period Decrease Increase From Distributions And Net Transfer To Shareholders And Other Affiliates
StockholdersEquityPeriodDecreaseIncreaseFromDistributionsAndNetTransferToShareholdersAndOtherAffiliates
4193093
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
51079
CY2023Q1 uhg Adjustments To Additional Paid In Capital Forfeiture Of Private Placement Warrants
AdjustmentsToAdditionalPaidInCapitalForfeitureOfPrivatePlacementWarrants
890001
CY2023Q1 uhg Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
17870584
CY2023Q1 uhg Stock Issued During Period Value Pipe Investment
StockIssuedDuringPeriodValuePipeInvestment
9501915
CY2023Q1 uhg Stock Issued During Period Value Lock Up Agreement
StockIssuedDuringPeriodValueLockUpAgreement
4236
CY2023Q1 uhg Adjustments To Additional Paid In Capital Recognition Of Derivative Liability Related To Earnout
AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeLiabilityRelatedToEarnout
242211404
CY2023Q1 uhg Adjustments To Additional Paid In Capital Recognition Of Derivative Liability Related To Equity Incentive Plan
AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeLiabilityRelatedToEquityIncentivePlan
1189685
CY2023Q1 uhg Adjustments To Additional Paid In Capital Earnout Stock Based Compensation Expense For Uhg Employee Options
AdjustmentsToAdditionalPaidInCapitalEarnoutStockBasedCompensationExpenseForUhgEmployeeOptions
4448077
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2932426
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-204504328
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-363261008
CY2023Q1 uhg Exchange Rate On Retroactively Restated Of Business Combination
ExchangeRateOnRetroactivelyRestatedOfBusinessCombination
373.47
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-204504328
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17017928
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85502
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
245808
CY2023Q1 us-gaap Depreciation
Depreciation
93942
CY2022Q1 us-gaap Depreciation
Depreciation
86829
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
56543
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
120988
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
85782
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4499156
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1268222
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
204138
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
133064
CY2023Q1 uhg Fair Value Adjustment Of Contingent Earnout Liability
FairValueAdjustmentOfContingentEarnoutLiability
203418892
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2723333
CY2023Q1 uhg Fair Value Adjustment Of Equity Incentive Plan
FairValueAdjustmentOfEquityIncentivePlan
922263
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-197768
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1392182
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1251423
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30062060
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8418953
CY2023Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
1787241
CY2022Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
121691
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10027
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-850943
CY2023Q1 uhg Increase Decrease In Deferred Tax Asset
IncreaseDecreaseInDeferredTaxAsset
2021265
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11443196
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2209396
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-204138
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-133064
CY2023Q1 uhg Dues To Related Parties
DuesToRelatedParties
59825
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-314908
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1078591
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23051836
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10507683
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59229
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19295
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66100
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
49000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6871
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68295
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
40000000
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
20000000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
40579214
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
22226052
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
136773
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2154624
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5877
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
469585
CY2023Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
17896302
CY2022Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
25390972
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
71500000
CY2023Q1 uhg Proceeds From Pipe Investment And Lock Up
ProceedsFromPipeInvestmentAndLockUp
4720427
CY2023Q1 uhg Proceeds From Business Combination Net Of Spac Transaction Costs
ProceedsFromBusinessCombinationNetOfSpacTransactionCosts
30336068
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12134293
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
75613874
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25468277
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
98672581
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15028889
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12238835
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51504887
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110911416
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36475998
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2315023
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
846181
CY2022Q1 uhg Additions Of Right Of Use Lease Assets And Liabilities
AdditionsOfRightOfUseLeaseAssetsAndLiabilities
1149832
CY2022Q1 uhg Acquisition Of Developed Lots From Related Parties In Settlement Of Due From Other Affiliates
AcquisitionOfDevelopedLotsFromRelatedPartiesInSettlementOfDueFromOtherAffiliates
4624810
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
665020
CY2023Q1 uhg Transfer Of Co Obligor Debt To Land Development Affiliate
TransferOfCoObligorDebtToLandDevelopmentAffiliate
8340545
CY2023Q1 uhg Transfer Of Guarantor From Gsh To Shareholder
TransferOfGuarantorFromGshToShareholder
2841034
CY2022Q1 uhg Noncash Distribution To Owner S Of Other Affiliates
NoncashDistributionToOwnerSOfOtherAffiliates
12671122
CY2023Q1 uhg Earnest Money Receivable From Other Affiliates
EarnestMoneyReceivableFromOtherAffiliates
2521626
CY2023Q1 uhg Recognition Of Previously Capitalized Deferred Transaction Costs
RecognitionOfPreviouslyCapitalizedDeferredTransactionCosts
2932426
CY2023Q1 uhg Modification To Existing Lease
ModificationToExistingLease
40078
CY2023Q1 uhg Recognition Of Derivative Liability Related To Earnout
RecognitionOfDerivativeLiabilityRelatedToEarnout
242211404
CY2023Q1 uhg Recognition Of Derivative Liability Related To Equity Incentive Plan
RecognitionOfDerivativeLiabilityRelatedToEquityIncentivePlan
1189685
CY2023Q1 uhg Recognition Of Warrant Liability Upon Business Combination
RecognitionOfWarrantLiabilityUponBusinessCombination
1531000
CY2023Q1 uhg Forfeiture Of Private Placement Warrants Upon Business Combination
ForfeitureOfPrivatePlacementWarrantsUponBusinessCombination
890001
CY2023Q1 us-gaap Stock Issued1
StockIssued1
39933707
CY2023Q1 uhg Recognition Of Deferred Tax Asset Upon Business Combination
RecognitionOfDeferredTaxAssetUponBusinessCombination
1870310
CY2023Q1 uhg Recognition Of Income Tax Payable Upon Business Combination
RecognitionOfIncomeTaxPayableUponBusinessCombination
701871
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
-3588110
CY2023Q1 uhg Non Cash Investing And Financing Activities
NonCashInvestingAndFinancingActivities
320147937
CY2022Q1 uhg Non Cash Investing And Financing Activities
NonCashInvestingAndFinancingActivities
5774642
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4700000
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
47594950
CY2023Q1 uhg Ownership Percentage
OwnershipPercentage
1
CY2023Q1 uhg Transaction Costs Including Advisory Banking Legal And Other Professional Fees
TransactionCostsIncludingAdvisoryBankingLegalAndOtherProfessionalFees
25700000
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates – </i>The preparation of the accompanying Condensed Consolidated Financial Statements in conformity with GAAP requires management to make informed estimates and judgments that affect the amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Estimates made by the Company include corporate expense allocation, useful lives of depreciable assets, revenue recognition associated with contracts recognized over time, capitalized interest, warranty reserves, share-based compensation, valuation of earnout liability, valuation of convertible note and valuation of stock warrants. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may differ from those estimates.</p>
CY2023Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
21189983
CY2022Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
16205448
CY2023Q1 uhg Inventory Land Held For Development And Sale Portion Purchased
InventoryLandHeldForDevelopmentAndSalePortionPurchased
15815143
CY2022Q4 uhg Inventory Land Held For Development And Sale Portion Purchased
InventoryLandHeldForDevelopmentAndSalePortionPurchased
10052179
CY2023Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
88872575
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
141863561
CY2023Q1 us-gaap Inventory Finished Homes
InventoryFinishedHomes
40078317
CY2022Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
22133926
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
490980
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
452765
CY2023Q1 uhg Term For Which Shares Or Warrants Not Transferable Assignable Or Salable
TermForWhichSharesOrWarrantsNotTransferableAssignableOrSalable
P30D
CY2023Q1 uhg Common Stock Warrants Exercised
CommonStockWarrantsExercised
0
CY2022Q1 uhg Number Of Freestanding Financial Instruments
NumberOfFreestandingFinancialInstruments
2
CY2022Q1 uhg Proceeds From Freestanding Instruments Issued
ProceedsFromFreestandingInstrumentsIssued
75000000.0
CY2022Q1 uhg Proceeds Allocated To Notes
ProceedsAllocatedToNotes
70200000
CY2022Q1 uhg Proceeds Allocated To Shares
ProceedsAllocatedToShares
4800000
CY2023Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
193100000
CY2023Q1 uhg Fair Value Transfer From Levels Amount
FairValueTransferFromLevelsAmount
0
CY2022Q4 uhg Fair Value Transfer From Levels Amount
FairValueTransferFromLevelsAmount
0
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1636931
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1250460
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1190318
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
2237900
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
837780
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
2386832
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
957900
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1101528
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1070198
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1819691
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3022629
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1143283
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
676408
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1385698
CY2023Q1 us-gaap Depreciation
Depreciation
93942
CY2022Q1 us-gaap Depreciation
Depreciation
86829
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
120797006
CY2023Q1 uhg Outstanding Debt Balance
OutstandingDebtBalance
0
CY2023Q1 uhg Overhead Costs Allocated To Related Party
OverheadCostsAllocatedToRelatedParty
185812
CY2023Q1 uhg Street Maintenance Related Party
StreetMaintenanceRelatedParty
59825
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
125987
CY2023Q1 uhg Purchase Option Deposit Percentage
PurchaseOptionDepositPercentage
0.10
CY2023Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
8113303
CY2022Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
3804436
CY2023Q1 us-gaap Land Under Purchase Options Not Recorded
LandUnderPurchaseOptionsNotRecorded
205808168
CY2022Q1 us-gaap Land Under Purchase Options Not Recorded
LandUnderPurchaseOptionsNotRecorded
65451928
CY2023Q1 uhg Purchase Option Total Contract Value
PurchaseOptionTotalContractValue
213921471
CY2022Q1 uhg Purchase Option Total Contract Value
PurchaseOptionTotalContractValue
69256364
CY2023Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
8113303
CY2023Q1 uhg Purchase Agreement Deposits Outstanding Related Party
PurchaseAgreementDepositsOutstandingRelatedParty
4595626
CY2023Q1 uhg Cost Of Sales Write Off Of Forfeited Purchase Option Deposits
CostOfSalesWriteOffOfForfeitedPurchaseOptionDeposits
8664
CY2022Q1 uhg Cost Of Sales Write Off Of Forfeited Purchase Option Deposits
CostOfSalesWriteOffOfForfeitedPurchaseOptionDeposits
89361
CY2023Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P5Y
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
201439
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
159679
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
11925
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
18237
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0316
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M9D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2023Q1 uhg Number Of Units In Sale Leaseback Arrangement
NumberOfUnitsInSaleLeasebackArrangement
19
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
68625
CY2023Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
361734
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
292992
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
108792
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
48000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
811518
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
43236
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
768282
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
95381
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
34335
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
870567
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
85555
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
785012
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
197912
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4400000
CY2023Q1 uhg Derivative Instrument Contingent Consideration Liability Earnout
DerivativeInstrumentContingentConsiderationLiabilityEarnout
0
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17017928
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37575074
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37347350
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2021265
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
821811
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.253
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1199454
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Employees Gross Pay One
DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPayOne
0.03
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Match One
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne
1
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Match Two
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo
0.50
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Employees Gross Pay Two
DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPayTwo
0.02
CY2021Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2021Q1 uhg Defined Contribution Plan Vesting Percentage After Completing Six Years Of Service
DefinedContributionPlanVestingPercentageAfterCompletingSixYearsOfService
1
CY2021Q1 uhg Defined Contribution Plan Service Term Required For Full Vesting
DefinedContributionPlanServiceTermRequiredForFullVesting
P6Y
CY2023Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
80077
CY2022Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
37652
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-204504328
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37575074
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37347350
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.44
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.44
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22358327
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2811630
CY2023Q1 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
21886378

Files In Submission

Name View Source Status
uhg-20230331_cal.xml Edgar Link unprocessable
0001104659-23-060949-index-headers.html Edgar Link pending
0001104659-23-060949-index.html Edgar Link pending
0001104659-23-060949.txt Edgar Link pending
0001104659-23-060949-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uhg-20230331.xsd Edgar Link pending
uhg-20230331x10q.htm Edgar Link pending
uhg-20230331xex31d1.htm Edgar Link pending
uhg-20230331xex31d2.htm Edgar Link pending
uhg-20230331xex32d1.htm Edgar Link pending
uhg-20230331xex32d2.htm Edgar Link pending
uhg-20230331_def.xml Edgar Link unprocessable
uhg-20230331_lab.xml Edgar Link unprocessable
uhg-20230331_pre.xml Edgar Link unprocessable
uhg-20230331x10q_htm.xml Edgar Link completed